Therapeutic angiogenesis using gene transfer and stem cell therapy in peripheral artery disease;Therapeutische Angiogenese mittels Gen- und Stammzellentherapie bei der peripheren arteriellen Verschlusskrankheit

Deutsche Medizinische Wochenschrift

Volumn 136, Issue 14, 2011, Pages 672-674

  Nikol, S ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

angiogenesis; peripheral artery disease; stem cell therapy

Indexed keywords

ANTIANGIOGENIC GENE THERAPY; ANTIANGIOGENIC THERAPY; ARTICLE; GENE TRANSFER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; STEM CELL TRANSPLANTATION;

AMPUTATION; ANGIOGRAPHY; ARTERIAL OCCLUSIVE DISEASES; CONTROLLED CLINICAL TRIALS AS TOPIC; FIBROBLAST GROWTH FACTOR 1; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; NEOVASCULARIZATION, PHYSIOLOGIC; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT FAILURE;

EID: 79953271480     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1274561     Document Type: Article

References (14)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner J M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 964-967 (Pubitemid 27087709)
2. Creager M, Olin J W., Belch J et al,. A randomized, double-blind, placebo-controlled, parallel group study of ad2/hypoxia inducible factor (HIF-1a/vp16) in patients with intermittent claudication. Orlando, Florida American College of Cardiology (ACC) 58th Annual Scientific Session March 29 - 31, 2009
3. Isner J M., Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes J F. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996 348 370-374 (Pubitemid 26261511)
4. Kusumanto Y H., van Weel V, Mulder N H., Smit A J., van den Dungen J J., Hooymans J M., Sluiter W J., Tio R A., Quax P H., Gans R O., Dullaart R P., Hospers G A. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 2006 17 683-691 (Pubitemid 43970708)
5. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 2010 103 696-709
6. Makinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E, Yla-Herttuala S. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002 2 127-133 (Pubitemid 36124280)
7. Nikol S, Baumgartner I, Van Belle E, Diehm C, Visoná A, Capogrossi M C., Ferreira-Maldent N, Gallino A, Wyatt M G., Wijesinghe L D., Fusari M, Stephan D, Emmerich J, Pompilio G, Vermassen F, Pham E, Grek V, Coleman M, Meyer F TALISMAN 201 investigators. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 2008 16 972-978 (Pubitemid 351587109)
8. Powell R J., Goodney P, Mendelsohn F O., Moen E K., Annex B H., HGF-0205 Trial Investigators. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF- 0205 trial. J Vasc Surg 2010 52 1525-1530
9. Rajagopalan S, Mohler 3rd E R., Lederman R J., Mendelsohn F O., Saucedo J F., Goldman C K., Blebea J, Macko J, Kessler P D., Rasmussen H S., Annex B H. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003 108 1933-1938 (Pubitemid 37296537)
10. Sprengers R W., Moll F L., Verhaar M C. Stem cell therapy in PAD. Eur J Vasc Endovasc Surg 2010 39 Suppl 1 S38-43
11. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T, Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002 360 427-435
12. US National Institutes of Health. A Phase 2, randomized, double-blind, placebo-controlled, parallel-group, multicenter, dose-selection study of Ad2/Hypoxia Inducible Factor (HIF)-1/VP16 in patients with intermittent claudication. http://clinicaltrials.gov/ ct2/show/NCT00117650?term= WALK+HIF-1+alpha&rank=1 (letzter Zugriff 3.3.2011)
13. Walter D. PROVASA-Studie, Präsentation im Rahmen des Leipzig Interventional Course- LINC- 2010.
14. Hiatt W R., Baumgartner I, Nikol S, Van Belle E, Driver V, Norgren L, Belch J, (TAMARIS steering committee). http://www.slideshare.net/alizotte/aha- tamaris (letzter Zugriff 3.3.2011)